Headquarters: Ann Arbor, Michigan, United States
Funding Status: M&A
Investors Number: 12
Founded Date: 2009
Last Funding Type: Venture - Series Unknown
Total Funding: $106M
Industry: Gene Therapy
Estimated Revenue: Less than $1M
Technology: Neurological Disorders